Whether axitinib (Inlida) can be taken with food and its impact on absorption

Axitinib is an oral small molecule vascular endothelial growth factor receptor (VEGFR) inhibitor, mainly used to treat advanced renal cell carcinoma. Its pharmacological effects inhibit tumor angiogenesis by inhibiting the VEGFR signaling pathway, thereby inhibiting tumor growth and metastasis. For patients, drug absorption and bioavailability have a significant impact on efficacy, so attention to detail is required in how medications are taken.

Judging from clinical studies and drug instructions, axitinib can be taken with food or on an empty stomach. Food has a relatively limited impact on drug absorption. Compared with fasting, taking axitinib with food will not significantly change the blood concentration of the drug, nor will it affect the efficacy. Patients can choose to take medication at a fixed time according to their own habits, but the medication time should be kept relatively consistent every day to maintain stable blood concentration.

Although axitinib can be taken with food, it is still recommended to avoid taking the drug with high-fat or greasy meals, as extremely high-fat meals may slightly affect the absorption rate of the drug, causing fluctuations in blood concentration. A stable diet and regular medication can help optimize efficacy and reduce the risk of side effects. If indigestion or stomach discomfort occurs, you can choose to take the medicine with or after a meal under the guidance of a doctor to improve tolerance.

In addition, while taking axitinib, patients should be careful not to take it with drugs or supplements that affect gastrointestinal absorption. For example, some antacids containing magnesium or aluminum may affect the absorption of axitinib. To ensure efficacy and safety, it is recommended that patients take medication strictly in accordance with doctor's instructions, maintain a fixed medication time and method, and regularly review indicators such as blood pressure and renal function to ensure the stability and effectiveness of treatment.

Reference materials:https://www.drugs.com/